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Abstract: Metabotropic GABAB receptors are known to modulate the activity 
of voltage-dependent calcium channels. Previously, we have shown that 
GABAB receptors couple to a non-Gi/o G-protein to enhance calcium influx 
through L-type calcium channels by activating protein kinase C in neonatal rat 
hippocampal neurons. In this study, the components of this signaling pathway 
were investigated further. Gαq was knocked down using morpholino 
oligonucleotides prior to examining GABAB-mediated enhancement of calcium 
influx. When Gαq G-proteins were eliminated using morpholino-mediated 
knockdown, the enhancing effects of the GABAB receptor agonist baclofen 
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(10 μM) on calcium current or entry were eliminated. These data suggest that 
GABAB receptors couple to Gαq to regulate calcium influx. Confocal imaging 
analysis illustrating colocalization of GABAB receptors with Gαq supports this 
hypothesis. Furthermore, baclofen treatment caused translocation of PKCα 
(protein kinase C α) but not PKCβ or PKCε, suggesting that it is the α isoform 
of PKC that mediates calcium current enhancement. Inhibition of 
calcium/calmodulin-dependent kinase II did not affect the baclofen-mediated 
enhancement of calcium levels. In summary, activation of GABAB receptors 
during development leads to increased calcium in a subset of neurons through 
Gαq signaling and PKCα activation without the involvement of 
calcium/calmodulin-dependent kinase II. 
 
Activation of GABAB receptors in the neonatal rat hippocampus enhances 
voltage-dependent calcium currents independently of Gi/o. In this study, 
knockdown of Gαq with morpholino oligonucleotides abolished enhancement of 
calcium influx and protein kinase Cα was activated by GABAB receptors. 
Therefore, we hypothesize that GABAB receptors couple to Gq to activate PKCα 
leading to enhancement of L-type calcium current. 
Abbreviations used 
 
Ant-AIP-II Antennapodia sequence-fused autocamtide-2 related inhibitory 
peptide II 
CaMKII calcium/calmodulin-dependent protein kinase 2 
CREB cAMP response element-binding protein 
DAG diacylglycerol 
ERK1/2 extracellular signal-regulated kinase 1/2 
GIRK G-protein coupled inwardly rectifying potassium channel 
IIntide myristolated calmodulin kinase IINtide 
IOD integrated optical density 
IP3 inositol trisphosphate 
KCTD potassium channel tetramerization domain 
PCC Pearson's correlation coefficient 
PIP2 phosphatidylinositol 4,5-bisphosphate 
PKA protein kinase A 
PKC protein kinase C 
ROI region of interest 
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GABAB receptors are members of a large group of class C 7 
transmembrane G-protein coupled receptors, sharing structural 
similarities with metabotropic glutamate receptors (Kaupmann et al. 
1997). Uniquely, these receptors form heteromers, composed of a 
GABAB1 and GABAB2 subunit, which dimerize within the ER to be 
trafficked to the cell membrane. While there are allosteric interactions 
between the subunits during activation, the ligand binds the GABAB1 
subunit, and the G-protein interacts with GABAB2. Functionally, GABAB 
receptors may be either pre- or post-synaptic, and their activation is 
considered inhibitory via coupling to Gαi/o G-proteins. There are three 
well-described mechanisms of this inhibition: first, the α subunit of 
Gαi/o signaling inhibits adenylyl cyclase, reducing cAMP levels and/or 
protein kinase A (PKA) activation (Nishikawa et al. 1997). Second, 
calcium channels are directly inhibited by the βγ subunit. This reduces 
pre-synaptic neurotransmitter release and post-synaptic dendritic 
calcium spikes (Chalifoux and Carter 2011). Finally, GABAB receptor 
stimulation activates G-protein-coupled inwardly rectifying potassium 
channels, again through direct interaction with the βγ subunit 
(Reuveny et al. 1994; Wickman et al. 1994). In this case, potassium 
efflux generates inhibitory post-synaptic potentials which hyperpolarize 
the cell. 
While cases of GABAB receptor activation leading to inhibition 
have been well documented, there are reports demonstrating an 
enhancement of voltage-dependent calcium channel activity (Shen and 
Slaughter 1999; Carter and Mynlieff 2004; Bray and Mynlieff 2009, 
2011; Park et al. 2010; Im and Rhim 2012). In the hippocampus, 
long-lasting (L-type) current is facilitated in a subset of cells when 
GABAB receptors were activated by the GABAB receptor-specific ligand 
baclofen (Carter and Mynlieff 2004). This phenomenon is observed 
early in development, peaking at postnatal day 6 (P6) to P8 in rats 
(Bray and Mynlieff 2009). Furthermore, this GABAB receptor-mediated 
enhancement of calcium current was not sensitive to pertussis toxin, a 
known inhibitor of Gαi/o-mediated processes (Bray and Mynlieff 2011). 
Our laboratory demonstrated that this enhancement is dependent on 
protein kinase C (PKC) activation. Enhancement of calcium current was 
eliminated when global PKC inhibitors were used and treatment of cells 
with the PKC activator phorbol 12-myristate 13-acetate (PMA) 
mimicked the effect of activating GABAB receptors. However, 
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participants in the signaling pathway, such as specific G-proteins and 
isoforms of PKC, have not been previously investigated. 
This study sought to identify components of the GABAB receptor 
mediated increase in calcium current. Because the effect of calcium 
current enhancement was not sensitive to pertussis toxin, we 
hypothesized that GABAB receptors may couple to another G-protein 
besides Gαi/o. It is not likely a Gαs G-protein, because this pathway 
initiates PKA signaling. Instead, we hypothesized that the G-protein 
involved in this signaling pathway was a member of the Gαq family of 
G-proteins (Gαq, Gα11, Gα14, Gα15/16), which are known to activate PKCs 
through activation of phospholipase Cβ. To test this hypothesis, a 
morpholino-induced knockdown strategy was used to inhibit signaling 
of specific G-proteins. 
Next, the identity of the specific isoform of PKC that is involved 
in the signal transduction pathway was investigated. There are at least 
15 isoforms of PKC, separated into three families based on their 
requirements for activation. Conventional PKCs require calcium ions, 
diacylglycerol (DAG), and a phospholipid such as phosphotidylserine. 
Novel PKCs require DAG and a phospholipid, but not calcium ions; 
atypical PKCs require neither DAG nor calcium ions for activation. As 
PMA treatment mimics GABAB receptor activation, the isoform was not 
likely to be atypical. Furthermore, the highest proportion of neurons 
demonstrating current enhancement occurs at P7. Different PKC 
isoforms demonstrate different temporal expression, so those isoforms 
which are highly expressed at P7, and also not of the atypical family, 
were examined using translocation to the membrane as a measure of 
activation. 
Finally, the involvement of calcium/calmodulin-dependent 
kinase II (CaMKII) as a component of the signaling cascade was 
investigated. It has been shown previously that CaMKII is required in 
other G-protein pathways which result in calcium current enhancement 
(O-Uchi et al. 2008). In addition, CaMKII is known to phosphorylate L-
channels, thereby increasing current (Hudmon et al. 2005; Abiria and 
Colbran 2010). Thus, we hypothesized that PKC may activate CaMKII, 
which in turn phosphorylates the calcium channel. Results presented 
here provide evidence that the GABAB receptor couples to Gαq in 
neonatal hippocampal neurons, causing PKCα to translocate to the cell 
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membrane, where it putatively interacts with L-type calcium channels, 
bypassing the involvement of CaMKII. 
Methods 
Isolation of hippocampal neurons 
All animal protocols were approved by the Marquette University 
Institutional Animal Care and Use Committee according to guidelines 
set forth by the National Research Council in the Guide for the Care 
and Use of Laboratory Animals. Hippocampal neurons were obtained 
from P6–P8 Sprague–Dawley rat pups of either sex (Onsite breeding 
colony, parents from Charles River Laboratories; Mynlieff 1997). 
Briefly, pups were anesthetized with 100% CO2 and decapitated. Using 
sterile technique, the superior regions of the hippocampi were 
dissected, diced, and incubated in oxygenated PIPES-buffered saline 
with 0.5% Trypsin XI and 0.01% DNase I (Sigma-Aldrich, St. Louis 
MO, USA). After a 30 min incubation at 22°C the tissue was placed in a 
35°C water bath for 60 min. After a series of rinses, the tissue was 
triturated and the cell suspension was plated onto poly-l-lysine coated 
dishes or glass coverslips (MW 38 500–60 000; Sigma Aldrich) and 
transferred to a 37°C 5% CO2 water-jacketed incubator. Cultures were 
maintained a minimum of 20 h before experiments to allow recovery 
from enzymatic digestion. 
Protein knockdown 
Knockdown of Gαq G-proteins in neuronal cultures was 
performed with morpholinos delivered by the Endo-Porter delivery 
system (Gene Tools LLC, Philomath, OR, USA). Morpholino 
oligonucleotides were designed to sterically inhibit translation of Gαq 
mRNA (Entrez ID: 13591956 NM_031036, 
5′ACGCCATGATGGACTCCAGAGTCAT); negative nonsense controls 
(5′AAACCCGGGTTTACG) were used to insure specificity of the target 
oligo. Morpholinos were synthesized with a 3′ carboxyfluorescein tag 
to visualize delivery. Endo-Porter peptide (final concentration 4 μM) 
and morpholino oligos (final concentration 2 μM) were added one time 
to the Neurobasal-A media in the culture dishes immediately after 
dissociation of the cells. Delivery of oligos and cell viability was 
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assessed at 24, 48, and 96 h post delivery to insure cargo was 
delivered and cell health was not negatively impacted. 
Western blot analysis 
Whole hippocampal tissue or neurons from hippocampal cultures 
were obtained from rat pups age P6–P8. For whole tissue samples, 
hippocampi were dissected and homogenized in ice-cold buffer with 
protease inhibitors (250 mM sucrose, 10 mM Tris, 10 mM HEPES, 
1 mM EDTA, 1 μg/mL pepstatin, 1 μg/mL leupeptin, 0.5 mg/mL 
Pefabloc; Sigma Aldrich; pH 7.2 with HCl) followed by centrifugation at 
3287 g for 10 min at 4°C. The supernatant was centrifuged at 41473 g 
for 30 min at 4°C, and the pellet was re-suspended in buffer and 
stored at −80°C. For cultured cell samples, neurons were scraped from 
culture dishes in homogenization buffer with protease inhibitors. The 
sample was centrifuged at 25401 g for 10 min at 4°C, and the pellet 
was re-suspended in 5% of the original volume of buffer to 
concentrate the sample. The suspension was centrifuged at 3287 g for 
10 min, the supernatant was retained, and centrifuged at 41473 g for 
30 min. The pellet was re-suspended in 15% of the original volume of 
homogenization buffer and stored at −80°C. Protein concentrations 
were measured at 280 nm with a Biophotometer (Eppendorf, Enfield, 
CT, USA). 
NuPAGE® lithium dodecyl sulfate sample buffer and reducing 
agent (Life Technologies, Carlsbad CA, USA) were added to protein 
samples and the mixture was heated at 70°C for 10 min. The protein 
samples were run on a NuPAGE® Novex 12% Bis-Tris minigel and 
transferred to a polyvinylidene difluoride membrane (0.45 μM pore 
size) using NuPAGE® transfer buffer (Life Technologies). Membranes 
were washed with phosphate-buffered saline (PBS, 134.4 mM NaCl, 
4.36 mM KCl, 10.56 mM NaHPO4, 1.66 mM NaH2PO4, pH to 7.4 with 
HCl) and blocked for 2 h in PBS containing 0.05% Tween, 5% non-fat 
dry milk, and 0.1% bovine serum albumin at 22°C. Proteins on 
membranes were labeled with polyclonal rabbit anti-Gαq (anti-GNAQ, 
1 : 500-1 : 1000, GeneTex catalog# GTX114029, Irvine CA, USA) or 
polyclonal rabbit anti-Gα11 (1 : 500, GeneTex catalog# GTX118876) in 
blocking solution. After a 90 min wash in PBS with 0.05% Tween, 
membranes were incubated with goat anti-rabbit horseradish 
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peroxidase-conjugated secondary antibody (1 : 1000-1 : 2500, Pierce, 
Rockford IL, USA). The SuperSignal West Dura Extended Duration 
chemiluminescent enhancement kit (Pierce) was used to visualize the 
protein bands. The amount of protein loaded was verified by labeling 
the membranes with anti-β-tubulin antibodies (1 : 2000, Cell 
Signaling, Danvers MA, USA). Quantification of bands was performed 
by measuring the integrated optical density (IOD) for each band using 
Labworks 4.6 software (UVP, Upland CA, USA). In experiments where 
expression was knocked down, data were normalized by dividing the 
IOD of the band labeled with anti-G-protein antibodies with the IOD of 
the band in the same lane visualized with anti-β-tubulin antibodies. 
Electrophysiology 
Calcium currents were measured in whole cell voltage clamp 
mode using a Dagan 3900A patch clamp amplifier (Dagan Corporation, 
Minneapolis MN, USA), Digidata 1322A acquisition setup, and pClamp 
10.0 software (Molecular Devices, Sunnyvale CA, USA). Extracellular 
recording solution (pH 7.4 with CsOH, 310–320 mOsm/L) contained 
10 mM CaCl2, 145 mM tetraethylammonium chloride, 10 mM HEPES, 
and 1 μM tetrodotoxin (Tocris Bioscience, Ellisville MO, USA). 
Recording electrodes were pulled from borosilicate glass on a 
Flaming/Brown Micropipette Puller (model P87, Sutter Instrument Co., 
Novato CA, USA) to a resistance of 5–9 MΩ and filled with intracellular 
solution (140 mM Cs-aspartate, 5 mM MgCl2, 10 mM Cs2EGTA, 10 mM 
HEPES, 2 mM ATP-Na2, and 0.1 mM guanosine triphosphate; pH 7.4 
with CsOH, 300–310 mOsm/L). Cells were held at −80 mV and 
depolarized to +10 mV with a 300 ms pulse. Whole cell currents were 
electronically filtered at 1 kHz and digitized at 2 kHz. Linear 
components of leak current were subtracted post hoc by the passive 
resistance protocol in pClamp 10.0. The GABAB agonist (RS)-baclofen 
(Tocris Bioscience) was dissolved in HCl, diluted 1 : 1000 in recording 
solution to a final concentration of 10 μM and applied to neurons using 
a U-tube delivery system constructed with PE-10 polyethylene tubing 
housed in a glass tube. In experiments designed to test the effect of 
CaMKII inhibition, CaMKII inhibitors cell permeable autocamtide-2 
related inhibitory peptide (Ant-AIP-II, IC50 4 nM, catalog#189485, 
EMD Millipore, Billerica, MA, USA; Ishida et al. 1998) or myristolated 
calmodulin kinase IINtide (IINtide, IC50 50 nM, catalog#208921, EMD 
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Millipore; Chang et al. 1998) were also added to the baclofen solution 
and delivered via U-tube. 
Calcium current measurements were taken at the end of the 
300 ms depolarizing pulse to maximize the contribution of L-type 
channels to the total current while minimizing the contribution of N- 
and P/Q-type channels. A graph of elicited sustained current 
magnitude versus time was plotted, and a linear regression with 95% 
confidence interval was constructed to account for run-up or run-down 
of calcium current (Carter and Mynlieff 2004; Bray and Mynlieff 2011). 
A cell that showed an increase or decrease in sustained calcium 
current in response to baclofen displayed a current magnitude that fell 
outside the confidence interval. 
Calcium imaging 
Cultured neurons were incubated for 1 h in the dark at 22°C in 
calcium imaging Ringer's solution (CIR, 154 mM NaCl, 5.6 mM KCl, 
1 mM MgCl2, 2 mM CaCl2, 10 mM HEPES, 11 mM glucose, pH 7.4 with 
NaOH) with 5 μM Fura-2 acetoxymethyl ester (Fura-2 AM, Life 
Technologies). Cells were rinsed and incubated for 30 min at 22°C in 
CIR without FURA-2 AM to allow for de-esterification. Neurons were 
depolarized by perfusion of a high potassium solution (100 mM NaCl, 
50 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM HEPES, 11 mM glucose, 
pH to 7.4 with NaOH) to open voltage-gated calcium channels. 
Baclofen (10 μM) in CIR was perfused onto the cells for 15 s, followed 
by baclofen in high potassium solution for 30 s. CaMKII inhibitors were 
added to the CIR/baclofen solution for pre-treatment, then added to 
the high potassium/baclofen solution and applied via gravity. The 
fluorophore was excited at 340 and 380 nm, and emissions were 
measured at 510 nm using Slidebook 5.0 software (Intelligent 
Innovations, Denver CO, USA). 
To determine inherent variability of the system, a group of 
control neurons were treated with high potassium solution three 
consecutive times (N = 309). Response #1 and #3 were averaged as 
the ‘control’ and the percent change with response #2 was calculated 
as the ‘pseudo’ drug response. The response to the second application 
of high potassium gave an average of 101.5 ± 13.20 (standard 
deviation) percent change when compared with the average of the 
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responses to application #1 and #3. During experiments, neurons 
were stimulated three times; the first and third stimulations were high 
potassium alone, and the middle stimulation was high potassium with 
another agent. To determine the effect of agent application during 
stimulation 2, its value was compared to the averaged value of 
stimulations 1 and 3 (high potassium control stimulations). The 
percent change with agent treatment when compared with the 
averaged before and after values was classified as an increase or 
decrease for a particular cell if the percent change with baclofen in 
50 mM potassium solution was > 2 times the standard deviation 
(2 × 13.20) of the cellular response from the control neurons 
stimulated three times consecutively with high potassium solution 
alone. 
Immunostaining 
To analyze the colocalization of GABAB receptors and Gαq, 
hippocampi from P6 to P8 rats were dissected, fixed, frozen and sliced 
into 20 μm sections. Sections were permeabilized with 0.5% Triton X-
100 in PBS for 20 min and blocked with 10% goat serum (Invitrogen, 
Carlsbad, CA, USA) in PBS with 0.05% Triton X-100. The sections were 
incubated for 2 h with polyclonal rabbit anti-GNAQ (1 : 1000, Genetex 
catalog# GTX114029) and monoclonal mouse anti-GABABR1 (1 : 15, 
UC Davis Neuromab, catalog# 73-183, Davis, CA, USA) in PBS with 
0.05% Triton X-100 and 0.1% goat serum. After rinsing, sections were 
incubated with Dylight® 488-conjugated goat anti-rabbit IgG and 
Dylight® 550-conjugated goat anti-mouse IgG (Thermo Scientific, 
Rockford, IL, USA) in PBS with 0.05% Triton X-100 and 0.1% goat 
serum. After rinsing, mounting medium with DAPI (4′,6-diamidino-2-
phenylindole; Vector Laboratories, Burlingame, CA, USA) was applied 
to stain nuclei; the sections were covered with a glass coverslip and 
sealed. Sections were imaged with a Nikon Perfect Focus Ti-E confocal 
microscope and NIS Elements imaging software (Nikon Instruments, 
Melville, NY, USA). 
To quantify the colocalization of GABAB receptors and Gαq G-
proteins, regions of interest (ROI's) in the stratum oriens, pyramidal 
cell layer, and stratum radiatum were drawn for each image. A 
Pearson's correlation coefficient (PCC) was determined to quantify the 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Journal of Neurochemistry, Vol 135, No. 1 (October 2015): pg. 88-100. DOI. This article is © Wiley and permission has 
been granted for this version to appear in e-Publications@Marquette. Wiley does not grant permission for this article to 
be further copied/distributed or hosted elsewhere without the express permission from Wiley. 
10 
 
degree of colocalization of the two proteins in each ROI. The PCC 
measures overlap of pixels for the two fluorophores; the higher the 
PCC, the more likely that the two proteins are overlapping in that ROI. 
A PCC was determined for the 3 ROI's in each image (16 sections 
taken from three animals), then averaged across sections, such that 
there was a single PCC value for the stratum oriens, pyramidal cell 
layer, and stratum radiatum, respectively. 
To analyze the translocation of PKC, neuronal cultures were 
treated with 1 μM phorbol-12-myristate-13 acetate (PMA, Calbiochem, 
La Jolla CA, USA) or 10 μM baclofen for 10 min prior to fixation. Cells 
were fixed in a solution of 4% paraformaldehyde in PBS for 30 min at 
22°C, permeabilized in PBS with 0.5% Triton X-100 for 20 min and 
blocked with 10% goat serum in PBS with 0.05% Triton X-100 for 
45 min. The cells were incubated with either monoclonal rabbit anti-
PKCα (1 : 500 dilution, catalog# GTX61153, Genetex), polyclonal 
rabbit anti-PKCβ (1 : 200 dilution, catalog# E021184, EnoGene 
Biotech Co., Ltd., New York, NY, USA) or polyclonal rabbit anti-PKCε 
(1 : 1000 dilution, catalog# GTX 109028, Genetex) overnight at 4°C. 
Following two washes with PBS and 0.05% Triton X-100, cells were 
incubated with Dylight® 488-conjugated goat anti-rabbit secondary 
antibodies (1 : 500 dilution) for 1 h at 22°C. Mounting medium with 
DAPI was applied for visualization of nuclei, and cells were imaged on 
a Nikon Perfect Focus Ti-E confocal microscope and NIS Elements 
imaging software (Nikon Instruments). 
Statistics 
Comparisons of the number of cells that exhibited either 
enhancement of calcium entry with ratiometric imaging or 
enhancement of calcium current with electrophysiology in cells treated 
with morpholinos or CaMKII inhibitors were analyzed by a Chi-squared 
test. A one-way anova was performed on PCC values obtained for the 
different regions of the hippocampus using confocal image analysis of 
protein colocalization followed by Holm–Sidak pairwise comparisons. 
Differences in the number of cells demonstrating translocation of 
different PKC isoforms were analyzed with Fisher's exact test. 
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Results 
Morpholino oligos inhibit Gαq protein expression 
To verify that morpholino oligos were able to penetrate the cell 
membrane and were not detrimental to cell viability, cultures were 
treated with Endo-Porter and fluorescein-labeled morpholinos and 
examined after 24, 48, and 96 h of incubation. Figure 1a shows 
cultures after 96 h treatment. Cells maintained their characteristic 
shapes and exhibited growing processes. Figure 1b illustrates that 
essentially every cell exhibited some level of cytoplasmic fluorescence. 
Although fluorescence levels vary, no punctate fluorescence is seen, 
which would indicate morpholinos unable to exit endosomes. Visible 
fluorescence requires ten-fold higher concentrations of morpholino 
than are necessary to produce significant protein knockdown (Gene-
tools, 2015). At concentrations ≥ 4 μM of oligos or ≥ 6 μM Endo-
Porter, morpholinos began to negatively affect growth and viability of 
neuronal cultures (data not shown). Thus, 2 μM morpholino and 4 μM 
Endo-Porter were used in all experiments. To determine the 
effectiveness of morpholino-induced protein knockdown, neurons were 
treated with Endo-Porter alone, nonsense morpholinos, or morpholinos 
against Gαq and western blotting was performed at various time points 
after the treatment. Figures 1c and d show the timecourse of Gαq 
knockdown. As demonstrated in Fig. 1d, preparations treated for 48 h 
with morpholinos against Gαq appeared to have less Gαq than 
preparations treated with nonsense morpholinos. Cultures treated with 
Endo-Porter alone or nonsense morpholinos demonstrated normal 
levels of Gαq protein expression (e.g., see inset in Fig. 1d). Thus, using 
the Endo-Porter delivery system, Gαq protein expression in neuronal 
cultures was reduced without negatively impacting cell health or 
viability. As a result of the relatively long half-life of G-proteins 
(Derrien et al. 1996), all electrophysiological and calcium imaging 
experiments were performed following 48 h incubation with Gαq 
morpholinos to insure sufficient protein knockdown. 
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Figure 1.  (a) Differential interference contrast image of a hippocampal culture from a 
postnatal day 4 rat pup treated with 10 μM control morpholino oligos and 2 μM Endo-
Porter peptide, and maintained in culture for 96 h. (b) Fluorescent image of (a); oligos 
were tagged with carboxyfluorescein for visualization. (c) Western blot of proteins 
isolated from either a control culture (lane 1), a culture treated for 24 h (lane 2) or 
48 h (lane 3) with 2 μM Gαq oligos. Protein bands were visualized with Gαq antibodies 
and β-tubulin antibodies as a loading control. Gαq band densities were calculated by 
dividing the integrated optical density (IOD) of the Gαq band by the IOD of the β 
tubulin band to control for loading and expressed as percent of control. (d) Western 
blot analysis of six different preparations from cultured neurons treated for 48 h with 
nonsense oligos (N = 3, NS MO) or Gαq oligos (N = 3, Gq MO). The data were 
analyzed as in (c), with the average of the nonsense oligo-treated preparations 
defined as 100%. Data are expressed as mean ± SEM. The inset is an example of Gαq 
expression in control tissue compared to cells treated with nonsense morpholinos to 
demonstrate that the nonsense morpholinos do not cause non-specific knockdown of 
Gαq. (e) Western blot analysis of Gαq and Gα11 G-protein in the neonatal hippocampus. 
Analysis was performed using tissue from the superior region of the hippocampus and 
antibodies against either Gαq or Gα11 proteins. The left panel shows molecular weight 
markers (same experiment but exposed to film for 1 s). To visualize bands labeled 
with Gα11 antibody, 10 times more protein was loaded (right panel) than for lanes 
labeled with Gαq antibodies (center panel) and the exposure time was increased to 
10 min, compared with 3 min exposure for bands labeled with Gαq antibodies. 
Gαq protein is more highly expressed than Gα11 in 
neonatal hippocampus 
Gα11 shares 90% sequence similarity with Gαq, and both G-
proteins have a ubiquitous distribution pattern (Mizuno and Itoh 
2009). Therefore, it was important to determine whether there could 
be non-specificity in the morpholino knockdown of Gαq that may 
decrease Gα11 as well. Protein preparations from cultured cells treated 
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with Gαq or nonsense morpholinos were analyzed by western blotting 
using Gα11 antibodies. If the morpholinos were specific to Gαq, there 
would be no change in the level of Gα11. However, no Gα11 signal was 
detected, even in control cultures not treated with morpholinos or 
Endo-Porter (data not shown). This result was suggestive that either 
the basal level of Gα11 was too low to detect with western blotting in 
preparations of cultured neurons, or that the Gα11 antibody did not 
recognize its target. To determine if the Gα11 antibody could recognize 
Gα11 G-protein, protein samples were prepared from the superior 
region of fresh whole hippocampus so that the amount of protein 
loaded on the gel could be increased. The Gα11 antibody recognizes its 
target, but only if 10 times the amount of protein was loaded and the 
membrane was exposed to film for a longer period of time (Fig. 1e). 
When a lane loaded with 2 μg of protein was probed with Gαq 
antibody, the IOD was 7.2. When a lane loaded with 20 μg of protein 
was probed with Gα11 antibody, the IOD was 5.0 on the same film at 
the same exposure. These data suggest that the Gαq antibody 
recognizes its protein target without detecting any Gα11 protein. Thus, 
while it cannot be ruled out that the Gαq morpholino may non-
specifically knock down Gα11 G-protein, a more likely explanation is 
that while both G-proteins are present, only Gαq G-protein is knocked 
down. 
Inhibiting Gαq expression abolishes baclofen-mediated 
enhancement of voltage-dependent calcium entry or 
current 
Despite a lack of precedence for the GABAB receptor coupling to 
a Gαq family member, downstream actions, including PKC activation, 
were consistent with the actions of a Gαq type G-protein. Therefore, 
we chose to knock down Gαq and assess whether application of the 
GABAB receptor agonist baclofen (10 μM) could still lead to calcium 
current enhancement. Hippocampal neurons were treated with either 
nonsense or Gαq morpholinos, and enhancement of calcium entry or 
current was assessed with calcium imaging and electrophysiology. In 
the nonsense morpholino-treated cells, 6 of 64 cells (9.37%) 
demonstrated an enhancement of high potassium induced calcium 
entry with baclofen treatment using calcium imaging (Fig. 2a). Of the 
207 cells treated with Gαq morpholinos, no cells demonstrated an 
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enhancement of high potassium-induced calcium entry with baclofen 
(Fig. 2c, Chi square, p < 0.001). Electrophysiology verified this result; 
in control cells treated with nonsense oligos, 3 of 25 cells 
demonstrated an enhancement of sustained calcium current when 
baclofen was applied (Fig. 2b). In contrast, no cells of 15 treated with 
Gαq morpholino oliogos for 48 h showed any calcium current 
enhancement (Fig. 2d). This set of experiments demonstrates that 
knockdown of the Gαq G-protein abolished enhancement of calcium 
current or entry upon GABAB receptor activation, linking a Gαq family 
member to this pathway and thus the GABAB receptor itself. 
 
Figure 2. Effect of 48 treatment with Gαq morpholino oligos on calcium entry in 
hippocampal neurons. Neurons were treated for 48 h with nonsense morpholino oligos 
(a and b) or Gαq morpholino oligos (c and d). (a and c) Increases in intracellular 
calcium were measured with ratiometric calcium imaging and reported as the 340/380 
ratio. Neurons were stimulated with high potassium, followed by a pre-treatment with 
10 μM baclofen and baclofen in high potassium (see 'Methods'). Each colored line 
represents a single cell. (b and d) Calcium currents were elicited by a 300 ms 
depolarizing pulse to +10 mV from a holding potential of −80 mV in the absence 
(green trace) and presence of 10 μM baclofen (red trace). 
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GABAB receptors colocalize with Gαq G-proteins 
When hippocampal sections were labeled with anti-GABAB 
receptor antibodies (red), nearly all areas were labeled, with the 
exception of the granule cells in the dentrate gyrus (Fig. 3a). At high 
magnification, there was an absence of nuclear labeling with GABAB 
antibodies, with a clear delineation between the nuclei and the labeling 
(Fig. 3e and h). Antibodies against Gαq labeled cells within both the 
pyramidal cell layer and the granule cell layer (Fig. 3b and f). In 
addition, there appeared to be individual cell bodies labeled within the 
stratum oriens and stratum radiatum without any diffuse labeling 
throughout these layers, as seen with GABAB antibodies. At low 
magnification, colocalization of the two fluorphores was most evident 
in the pyramidal cell layer and is absent from the dentate gyrus 
granule cell layer (see white arrows indicating pyramidal cell layer and 
granule cell layer; Fig. 3c and d). Quantitative analysis done at high 
magnification in the superior region of the hippocampus supports 
qualitative evidence seen at low magnification (Fig. 3c and g). The 
average Pearson's Correlation Coefficient (PCC), used to determine 
colocalization, was 0.125 ± 0.03 (SEM) in the stratum oriens. The PCC 
was 0.476 ± 0.03 in the pyramidal cell layer and 0.102 ± 0.01 in the 
stratum radiatum. The colocalization of GABAB receptors and Gαq is 
highest in the pyramidal cell layer, as suggested by the PCC value; the 
PCC is significantly higher in the pyramidal cell layer than either the 
stratum oriens or stratum radiatum (Fig. 3g; One-way anova followed 
by Holm–Sidak pairwise comparison, p < 0.001). A small number of 
neurons in both the stratum radiatum and the stratum oriens were 
labeled by antibodies against Gαq, and some of these neurons also 
appeared to be labeled with GABAB receptor antibodies (Fig. 3i, 
arrowhead). These neurons had a relatively high (0.5–0.75) PCC 
value. The functional significance or physiological identity of these 
neurons is unknown. 
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Figure 3. GABAB receptors colocalize with Gαq G-proteins in rat hippocampus. 
Hippocampal sections were labeled with polyclonal rabbit anti-GNAQ and monoclonal 
mouse anti-GABABR1 followed by Dylight® 488-conjugated goat anti-rabbit IgG 
(green) and Dylight® 550-conjugated goat anti-mouse IgG (red) for visualization. 
Nuclei were stained blue with DAPI. Colocalization of the red and green fluorophore 
appears yellow in the merged images (c, d, g, h, and i). (a–d) Low magnification 
images showing the whole section of hippocampus. (e–h) High magnification images 
showing the pyramidal cell layer (P), the stratum oriens (O), or the stratum radiatum 
(R). A small number of cells in both the stratum oriens and stratum radiatum 
appeared to show colocalization of GABAB and Gαq with a high Pearson's correlation 
coefficient (PCC) value. (i) Expansion of a high magnification image demonstrating 
colocalization(white arrowhead). (j) control sections (high magnification) processed 
without primary antibodies demonstrate autofluorescence of blood vessels. DG dentate 
gyrus. Scale bar in panel (high magnification) J = 10 μm. 
CaMKII activity is not involved in GABAB receptor-
mediated increases in intracellular calcium 
Cultured neurons were depolarized with 50 mM potassium 
solution, followed by a 50 mM potassium solution containing both 
10 μM baclofen and a cell permeable CaMKII inhibitor, Ant-AIP-II 
(50 nM). Both baclofen and Ant-AIP-II were applied during a 15 s pre-
treatment period as well as during the high potassium application. 
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Twenty-two of 255 (8.63%) cells imaged continued to demonstrate an 
increased 340/380 ratio, despite the presence of the inhibitor. When 
the inhibitor/baclofen solution was washed off, the response returned 
to original levels (Fig. 4a). Because there have been reports of non-
specific actions of CaMKII inhibitors on voltage-dependent calcium 
channels (Gao et al. 2006; Karls and Mynlieff 2013), the result was 
confirmed using a second cell permeable inhibitor, IINtide (250 nM). A 
similar result was obtained, where 47 of 432 (10.88%) neurons 
showed a reversible increase in 340/380 ratio when baclofen was co-
applied with IINtide (Fig. 4b). These values were not significantly 
different from control cells treated with baclofen alone, where 46 of 
392 (11.73%) of cells showed increases in the high potassium-
stimulated 340/380 ratio (Fig. 4c, Chi square). Electrophysiological 
recordings were performed in the presence and absence of 50 nM Ant-
AIP-II and 10 μM baclofen. The calcium current enhancement 
displayed when Ant-AIP-II was co-applied with baclofen was not 
significantly different than that seen with baclofen alone (Fig. 4d). In 
these experiments, 4 of 23 (17.39%) cells treated with Ant-AIP-II and 
baclofen displayed a significant increase in calcium current. In control 
cells, 6 of 27 (22.22%) displayed a significant increase when treated 
with baclofen alone. Thus, since neither inhibitor blocked the 
enhancement of calcium entry or current, it is likely that CaMKII is not 
involved in the pathway where activation of GABAB receptors results in 
increased calcium entry via L-type channels. 
 
Figure 4. The increase in calcium entry as a result of GABAB receptor activation with 
baclofen is not affected by calcium/calmodulin-dependent protein kinase 2 (CaMKII) 
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inhibitors. Neurons were stimulated with high potassium, followed by a pre-treatment 
with 10 μM baclofen with or without a CaMKII inhibitor followed by baclofen and 
CaMKII inhibitor in high potassium for ratiometric calcium experiments. Each colored 
line in (a and b) represents a single cell. Enhancement of calcium influx by baclofen 
persists in the presence of CaMKII inhibitor Antennapodia sequence-fused 
autocamtide-2 related inhibitory peptide II (Ant-AIP-II) (a, 50 nM) or myristolated 
CaMKII inhibitor IINtide (b, 250 nM). Concentrations chosen were 5–10 fold higher 
than the reported IC50 values. (c) There is no significant difference in number of cells 
demonstrating a baclofen-mediated increase in calcium influx when either CaMKII 
inhibitor is present in comparison to control cultures without (Chi square, total N is 
inset in each bar). (d) Electrophysiological recording shows persistent calcium current 
enhancement when baclofen (left) or baclofen and Ant-AIP-II (right) are present (red 
line) compared to a control trace (green line). 
PKCα translocates to the membrane upon GABAB 
receptor activation 
Analysis of immunohistochemical images with confocal 
microscopy was utilized to determine whether PKCα, PKCβ, or PKCε 
was translocated from the cytosol to the plasma membrane followed 
by 10 min treatment of cultured hippocampal neurons with baclofen 
(10 μM). A previous study demonstrated that activation of PKC by 
phorbol esters mimicked the effect of GABAB receptor stimulation on 
calcium currents in cultured hippocampal neurons (Bray and Mynlieff 
2011). Therefore, only phorbol ester-sensitive isoforms of PKC that are 
expressed in the early neonatal period were tested (Tanaka and 
Nishizuka 1994; Roisin and Barbin 1997). Cells were either treated 
with no drugs (unstimulated) or with the phorbol ester PMA (1 μM) to 
verify that the translocation to the membrane was apparent in confocal 
images. Fig. 5a demonstrates that both treatment with PMA and 
baclofen caused translocation of PKCα from the cytosol to the plasma 
membrane. A small percent of cells in each culture demonstrated 
spontaneous translocation of all three isoforms of PKC examined in 
unstimulated cultures (Fig. 5b; 2.99–7.69%, N = 104–568). All three 
isoforms translocated to the plasma membrane upon exposure to 
10 min of 1 μM PMA in a subset of cells (50.17% of 291 cells for PKCα, 
20.34% of 188 cells for PKCβ, 27.59% of 203 cells for PKCε). Only the 
percentage of cells demonstrating translocation of PKCα with baclofen 
treatment (9.83%, N = 478) was significantly higher than the percent 
of cells demonstrating spontaneous translocation in unstimulated 
conditions (2.99%, N = 568; Fisher's exact test, p < 0.0001). 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Journal of Neurochemistry, Vol 135, No. 1 (October 2015): pg. 88-100. DOI. This article is © Wiley and permission has 
been granted for this version to appear in e-Publications@Marquette. Wiley does not grant permission for this article to 
be further copied/distributed or hosted elsewhere without the express permission from Wiley. 
19 
 
 
Figure 5. Activation of GABAB receptors causes translocation of PKCα. (a) Cultured 
hippocampal neurons were treated with control media, the phorbol ester phorbol 12-
myristate 13-acetate (PMA) (1 μM) in media, or baclofen (10 μM) in media for 10 min 
before immunostaining. The scale bar in the lower right corner is 20 μm. (b) The 
percent cells demonstrating translocation of PKCα, PKCβ, and PKCε in control cultures 
(black bars) was compared to the percent cells demonstrating translocation of PKCα, 
PKCβ, and PKCε following stimulation with baclofen (gray bars). N = 568, 478, 104, 
183, 183, and 177 for the PKCα control, PKCα baclofen, PKCβ control, PKCβ baclofen, 
PKCε control, and PKCε baclofen, respectively. *p < 0.001, Fisher's exact test. 
Discussion 
Previous findings in our lab have shown that in neonatal 
hippocampus, GABAB receptor activation decreases calcium current in 
a subset of neurons via Gαi/o and enhances L-type calcium current in 
other neurons via a non-Gi/o G-protein (Carter and Mynlieff 2004; Bray 
and Mynlieff 2011). Despite a variation in percentage of neurons 
demonstrating calcium current enhancement (approximately 10% of 
neurons in calcium imaging versus 25% in electrophysiology), 
knocking down Gαq produced a consistent result – that enhanced 
calcium entry could be abolished. The variation in number of cells 
which demonstrate enhancement is likely because of the sampling of 
every cell within a field during calcium imaging experiments, whereas 
sampling in electrophysiology allows the experimenter to pick only the 
healthiest, best looking cells. While this percentage may at first appear 
low, the hippocampus is composed of no less than 37 different types of 
inhibitory interneurons (Ascoli 2013); thus a small percentage could 
encompass one or more of these 37 types, many of which have clearly 
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delineated functions of their own. While the subset of cells 
demonstrating a reduction in calcium current has been attributed to 
inhibition of calcium channels by Gαi/o G-proteins, the pathway 
describing calcium current enhancement upon GABAB receptor 
activation has not previously been explored. The data obtained in this 
study support a model in which GABAB receptors couple to Gαq 
activating PKCα to cause enhancement of voltage-dependent calcium 
current without the involvement of CaMKII (Fig. 6). 
 
Figure 6. The current model for the pathway which begins with GABAB receptor 
activation and results in enhanced L-type calcium current. Binding of ligand to the 
GABAB receptor leads to activation of a Gαq G-protein, which putatively activates 
phospholipase C. The activity of PLC hydrolyses PIP2 into diacylglycerol (DAG) and IP3, 
which can activate PKCα. PKCα bypasses calcium/calmodulin-dependent protein kinase 
2 (CaMKII) to lead to changes of the L-type calcium channel such that current is 
enhanced when the channel opens. 
We chose to determine the involvement of Gαq in the pathway 
because a similar bidirectional pathway involving both Gαq/11 
(mediating calcium current increase) and Gαi/o (mediating calcium 
current decrease) was observed in cardiac myocytes (O-Uchi et al. 
2008). In addition, activation of Gαq family members (Gαq, Gα11, Gα14, 
Gα15/16) are known to activate PKC by stimulating β isoforms of 
phospholipase C that hydrolyze phosphatidylinositol bisphosphate 
(PIP2), forming inositol tris-phosphate (IP3) and DAG (for review see 
(Rhee 2001). DAG and free calcium ions activate PKC, which then 
translocates from the cytosol to the cell membrane. Here, PKC may 
potentially phosphorylate the L-type calcium channel, either directly or 
indirectly through another second messenger. The phosphorylated 
channel putatively allows more calcium to enter when the cell is 
depolarized; biophysical changes to the channel have not yet been 
identified. 
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To test the model that Gαq is the G-protein that couples to the 
GABAB receptor, the translation of Gαq was inhibited by morpholinos, 
synthetic oligonucleotides that bind near the start codon of 5′ mRNA to 
inhibit binding of the ribosome. Morpholinos have several advantages 
over siRNA for knockdown of protein expression. siRNA are sensitive to 
intracellular enzymes, can trigger innate immune responses, and 
change the methylation state of DNA (Bayne and Allshire 2005; Judge 
et al. 2005; Kawasaki and Taira 2005; Marques and Williams 2005). 
None of these things occur with morpholinos (Hudziak et al. 1996) and 
they are easily taken up into cultured cells through endocytosis 
stimulated by the Endo-Porter peptide. The lack of enzymatic 
degradation makes morpholinos particularly useful to knock down 
proteins with a relatively long half-life, such as G-proteins. Despite 
these advantages, there is only one report of Endo-Porter mediated 
morpholino knockdown in mammalian neurons (Chih et al. 2006). 
Validation of protein knockdown demonstrated here highlights the 
usefulness of this technique. 
Western blot analysis indicated that the morpholinos were 
efficient in knocking down Gαq in primary hippocampal cultures, but it 
was important to verify the specificity of this knockdown. The most 
likely candidate for non-specific knockdown would be Gα11 because of 
high sequence homology with Gαq. The first 25 coding amino acids 
(the site of morpholino binding) are 92% identical. Data shown here 
suggest significantly higher expression of Gαq than Gα11 in neonatal 
hippocampus, consistent with other reports (Milligan 1993; Ihnatovych 
et al. 2002). However, caution must be used in interpreting these 
results. Because different antibodies were used to detect each protein, 
it is possible that Gα11 antibodies simply give a weaker signal than Gαq 
antibodies, even if there is abundant protein. Despite this, we believe 
that Gαq is expressed to a relatively higher degree than Gα11, both 
because of previous expression data, and the temporal expression 
pattern of Gαq. The high expression of Gαq relative to Gα11 makes it the 
most likely target of the morpholinos. It is also noteworthy that Gαq is 
most highly expressed during the first postnatal week (Ihnatovych 
et al. 2002), which corresponds to the time when the highest 
percentage of neurons demonstrates calcium current enhancement 
with baclofen (Bray and Mynlieff 2009). 
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Knockdown of Gαq eliminated the enhancement of calcium 
current by GABAB receptors supporting the hypothesis that Gαq is the 
G-protein that couples to the GABAB receptor. In addition, confocal 
imaging data demonstrated colocalization of Gαq and GABABRs. 
Mannoury La Cour et al. (2008) used an antibody-capture/scintillation 
proximity assay to show a lack of coupling between Gαq/11 and 
GABABRs (2008). However, this work reported the EC50 for baclofen at 
approximately 50 μM for Gαi/o coupling. These values are much higher 
than those used by others examining Gαi/o activation by GABABRs 
(Dolphin and Scott 1986; Sodickson and Bean 1996). Furthermore, the 
enhancing effect of baclofen is seen at high nanomolar concentrations 
while attenuation requires greater values (Shen and Slaughter 1999). 
Thus, it is possible that the assay used by Mannoury La Cour et al. 
(2008) is not sensitive enough to show Gαq/GABABR coupling at low 
agonist concentrations. 
The molecular interaction between the GABAB2 receptor subunit 
and Gαi/o involves both the second and third intracellular loops of 
GABAB2 (Duthey et al. 2002; Havlickova et al. 2002). This interaction 
occurs with the extreme C-terminus of the G-protein (Franek et al. 
1999). The lack of sequence homology between Gαi/o and Gαq suggest 
that Gαq must couple to the GABAR at sites unique to those examined. 
Identifying the sites of direct interaction between the GABABR and Gαq 
will support the physiological and colocalization data presented here. 
Although this is the first example of Gαq coupling to GABAB receptors, 
coupling to more than one G-protein has been shown for other G-
protein coupled receptors, including those that couple to both Gαq and 
Gαi/o (Offermanns and Simon 1995; Hawes et al. 2000; Macfarlane 
et al. 2001). We believe GABAB receptors to have the same ability, 
coupling to both Gαi/o to mediate classic inhibitory responses and Gαq 
to mediate calcium current enhancement. 
Enhancement of current by GABAB receptors may be mediated 
through a number of different mechanisms. It is possible that 
activation of GABAB receptors alone is sufficient to open L-type 
channels, as shown by Kuczewski et al. (2011). This report showed 
that application of 50 μM baclofen without depolarization caused an 
increase in calcium entry through L-type channels on the cell surface; 
however, we were unable to replicate this effect using the same 
concentration of baclofen on our P6–P8 cultured hippocampal neurons 
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(data not shown). GABAB receptors have been demonstrated to both 
increase and decrease potassium currents by interacting with different 
combinations of auxiliary potassium channel tetramerization domain-
containing subunits (Schwenk et al. 2010; Hayasaki et al. 2012). 
Hayasaki et al. point out that while these auxiliary subunits are most 
likely responsible for the bidirectional response observed, several 
factors, including G-protein diversity, may lead to differential effects in 
GABAB receptor signaling. Based on data presented here, we believe 
GABAB-mediated enhancement of L-type calcium current is because of 
its coupling to a Gαq G-protein through a novel pathway, rather than 
the canonical Gαi/o pathway. There are, however, other possible 
mechanisms for the observed effect. In airway smooth muscle, GABAB 
receptor stimulation led to activation of Gαi G-proteins and subsequent 
enhancement of calcium current; this study demonstrated that it was 
the βγ subunit of the G-protein which activated the same PLC/PKC 
pathway as Gαq (Mizuta et al. 2011). However, inhibiting Gαi/o 
signaling with pertussis toxin did not eliminate the observed 
enhancement in the hippocampus (Bray and Mynlieff 2009). It is also 
unlikely that the Gαq βγ subunit may be mediating this effect, because 
βγ signaling requires a functional α subunit interaction for proper 
assembly (Smrcka 2008). Therefore, while it is possible another 
mechanism exists in the GABAB receptor – L-type channel pathway, 
the most likely mechanism is GABAB coupling to Gαq. 
GABAB-receptor-mediated activation of PKC is not the only 
possible pathway involved. Previous studies in our laboratory 
examined if calcium current enhancement could be mediated by PKA 
(Bray and Mynlieff 2011). In this case, Gαs would likely couple to the 
GABAB receptor, leading to a cascade that would result in PKA, either 
in addition to or instead of PKC, phosphorylating the calcium channel. 
However, because enhancement was so clearly eliminated by 
knockdown of Gαq, and because baclofen caused PKC translocation, 
this G-protein is involved in mediating current enhancement. 
Furthermore, results of experiments designed to inhibit PKA with H-89 
were ambiguous in determining a role for PKA in the pathway. Thus, 
while PKA (and therefore Gαs) may be involved, we believe Gαq is 
responsible for GABAB-mediated calcium current enhancement. 
The regulation of L-type calcium channels by PKC has been 
reported to both increase and decrease calcium current, and the effect 
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on current seems to depend on the isoform of PKC involved. For 
example, phosphorylation by PKCε on the N terminus of CaV1.2 L-type 
calcium channels inhibits calcium current in cardiac cells (Yue et al. 
2004). However, phosphorylation of the C terminus of CaV1.2 by 
multiple PKC isoforms in HEK293 cells, including PKCα, led to an 
increase in L-type channel activity (Yang et al. 2009). Stimulation of 
PKCβII and PKCε with PMA decreased activity of Cav1.3 L-type calcium 
channels (Baroudi et al. 2006). Thus, identifying the PKC isoform in 
GABAB-mediated L-type current enhancement provides more detailed 
information regarding isoform-specific regulation of calcium channels. 
We have previously shown that activation of a phorbol ester-
sensitive PKC is required for GABAB-receptor-mediated enhancement 
of calcium current (Bray and Mynlieff 2011) and thus, here we sought 
to identify which isoform was involved. Of the 15 PKC isoforms 
identified only four have been shown to be robustly expressed in the 
early neonatal period and only three of these (α, β, and ε) fall into the 
categories of conventional or atypical PKCs that respond to phorbol 
ester stimulation. All three isoforms showed some basal level of 
translocation to the membrane (a measure of activation); however, 
only PKCα showed a significant increase in number of neurons showing 
translocation when treated with baclofen. Notably, the proportion of 
neurons that demonstrated this baclofen-mediated translocation of 
PKCα is approximately the same as the proportion that undergoes 
current enhancement. 
In an effort to describe as complete a pathway as possible, we 
examined the involvement of CaMKII in the signal transduction 
cascade. Evidence of CaMKII activation by PKC and phosphorylation of 
L-type channels in cardiac myocytes (O-Uchi et al. 2008) suggested 
that CaMKII may be a component here; however, when neurons were 
treated with CaMKII inhibitors Ant-AIP-II (50 nM) or myristolated 
CaMKIIntide (250 nM) plus baclofen, a subset of cells still showed 
calcium enhancement when depolarized. Although we cannot be sure 
that the incubation period was sufficient for the inhibitors to penetrate 
the cells at the applied concentration, the data suggest that CaMKII is  
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not part of the signaling pathway. 
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